About us

Mission, vision and values


Seqplexing is a biotechnology-based company that is focused on the creation of high-quality solutions to carry out genetic studies applicable in research and in the clinic. Our goal is to simplify and accelerate the achievement of results in genetic studies

We, therefore, develop solutions for different types of genetic studies that are very simple to use and implement. On the other hand, we also develop services that simplify numerous genetic studies applicable in research as in clinical practice

Health. The products and services of Seqplexing are mainly oriented to the improvement of human health through genetic tests that simplify and improve the genetic diagnosis in hereditary diseases and tumour markers (somatic mutations). In addition, our products and services also facilitate research into different aspects of genetics and epigenetics

Seqplexing activities

Our activities involve the development of genetic analysis, kits and services

All services can be done from any point of development, including complete studies from the initial idea or partial studies (application of a specific technique or analysis)



We are very happy to have been chosen as a Lexogen reference laboratory in Spain and Portugal thanks to Isogen Life Science.

All our products



Kits for the somatic or germline mutations detection by new generation or massive sequencing (NGS). Designed for use in samples from different sources: paraffin (FFPE), blood, saliva, FTAs, swabs, etc. Results from each of our kits will be analyzed by our software to facilitate work and the identification of mutations


The Myeloscreen kits allow the identification of specific fusion genes, present in diseases of myeloproliferative nature. These kits are based on a new multiplex PCR design, which allows simultaneous detection of the presence of the different isoforms of the existing translocation, by means of a one-step quantitative RT-PCR reaction (qRT-PCR ONE-STEP), from RNA samples. This system has an analysis tool that facilitates this work and allows obtaining the results in a very simple way. Currently we have kits for PML-RARA and BCR-ABL, allowing the detection of all isoforms described


Kits for the detection of copy number variants (CNVs). These kits are based on our own technology (EOSAL-CNV) and allow detecting the CNVs present in a sample in 2.5 hours with less than 10 minutes of handwork. This system has its own analysis tool that facilitates this work and allows to obtain the results in a very simple way. This system replaces MLPA or can be used to verify the CNVs detected with this or another system


Studies based on our kits

  • Detection of somatic and germline mutations
  • Detection of CNVs using EOSAL-CNV kits
  • Design of new studies and their application

  • Design of panels and customized kits for NGS
  • Design and studies using Q-PCR for the quantification of normal and chimeric genes, miRNAs, etc
  • Design and implementation of different types of studies, from initial design to full analysis
  • Studies using NGS:
    • Design of specific panels and their application to samples. Study by amplicons of complete genes, regions of interest, polymorphisms, methylation, hydroxymethylation, etc
    • Studies of transcriptome, methyloma, exome, metagenome, etc